On ECHEMI
Home > Drugs > Uterine malignancy
Uterine malignancy
Uterine malignancies can occur in the cervix, uterine body, and endometrium. Cervical cancer is one of the most common malignant tumors in gynecology. It refers to malignant tumors that occur in the vaginal part of the uterus and the cervical canal. The metastasis of cervical cancer can spread directly to adjacent tissues and organs, downward to the vaginal vault and vaginal wall, upward to the uterine body, to the sides to invade the pelvic tissue, forward to invade the bladder, and backward to invade the rectum. It can also metastasize to the paracervical, internal iliac, external iliac, and inguinal lymph nodes through lymphatic vessels, and even metastasize to the supraclavicular and other lymph nodes throughout the body in the late stage. Hematogenous metastasis is relatively rare, and common metastatic sites are the lungs, liver, and bones. When the symptoms of cervical cancer appear three months later, 2/3 of the patients have advanced cancer. Uterine body cancer is also called endometrial adenocarcinoma because it mostly originates from endometrial glands. It is more common in postmenopausal women, and the peak age of onset is 55 to 60 years old. The incidence rate is second only to cervical cancer. Microscopically, it can be divided into adenocarcinoma, glandular keratinizing carcinoma, squamous cell carcinoma, and clear cell carcinoma.
Related Drugs
Sodium norcantharinate injection
Indication: This product can be used for liver cancer, esophageal cancer, stomach and cardia cancer, lung cancer, and leukopenia. It can also be used as a preoperative medication for cancer or in combined chemotherapy.
Manufacturer:

Tianjin Pharmaceutical Heping (Tianjin) Pharmaceutical Co., Ltd.

Related Ingredients
  • SodiuM DeMethylcantharidate list

    13114-29-9
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.